Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project:
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Erlangen ; Nürnberg
Friedrich-Alexander-Universität Erlangen-Nürnberg
2022
|
Schlagworte: | |
Online-Zugang: | Volltext Volltext |
Beschreibung: | 1 Online-Ressource |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV049085276 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 230801s2022 gw |||| o||u| ||||||eng d | ||
016 | 7 | |a 1266055452 |2 DE-101 | |
024 | 7 | |a urn:nbn:de:bvb:29-opus4-215998 |2 urn | |
035 | |a (OCoLC)1392143850 | ||
035 | |a (DE-599)DNB1266055452 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |8 3\p |a eng | |
044 | |a gw |c XA-DE | ||
049 | |a DE-29 | ||
050 | 0 | |a R1 |2 lcc | |
084 | |8 1\p |a 615.3 |2 23ksdnb | ||
084 | |8 2\p |a 610 |2 23sdnb | ||
100 | 1 | |a Zeschick, Nikoletta |e Verfasser |4 aut | |
245 | 1 | 0 | |a Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project |c Nikoletta Zeschick, Lisette Warkentin, Thomas Kühlein, Philipp Steininger, Klaus Überla, Susann Hueber, Maria Sebastião |
264 | 1 | |a Erlangen ; Nürnberg |b Friedrich-Alexander-Universität Erlangen-Nürnberg |c 2022 | |
300 | |a 1 Online-Ressource | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
650 | 0 | |a Medicine. | |
650 | 0 | |a Statistics. | |
653 | |a Medicine/Public Health, general. | ||
653 | |a Biomedicine, general. | ||
653 | |a Statistics for Life Sciences, Medicine, Health Sciences. | ||
700 | 1 | |a Warkentin, Lisette |e Verfasser |4 aut | |
700 | 1 | |a Kühlein, Thomas |e Verfasser |4 aut | |
700 | 1 | |a Steininger, Philipp |e Verfasser |4 aut | |
700 | 1 | |a Überla, Klaus |e Verfasser |4 aut | |
700 | 1 | |a Hueber, Susann |e Verfasser |4 aut | |
700 | 1 | |a Sebastião, Maria |e Verfasser |4 aut | |
787 | 0 | 8 | |i Sonderdruck aus |t Pilot and Feasibility Studies |g Vol. 8 (2022) |o 10.1186/s40814-022-01088-y |
856 | 4 | 0 | |u https://open.fau.de/handle/openfau/21599 |x Verlag |z kostenfrei |3 Volltext |
856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-215998 |x Resolving-System |z kostenfrei |3 Volltext |
912 | |a ebook | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-034347135 | ||
883 | 0 | |8 1\p |a emakn |c 0,16263 |d 20220823 |q DE-101 |u https://d-nb.info/provenance/plan#emakn | |
883 | 0 | |8 2\p |a emasg |c 0,40103 |d 20220823 |q DE-101 |u https://d-nb.info/provenance/plan#emasg | |
883 | 1 | |8 3\p |a npi |d 20220822 |q DE-101 |u https://d-nb.info/provenance/plan#npi |
Datensatz im Suchindex
_version_ | 1804185417334915072 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author | Zeschick, Nikoletta Warkentin, Lisette Kühlein, Thomas Steininger, Philipp Überla, Klaus Hueber, Susann Sebastião, Maria |
author_facet | Zeschick, Nikoletta Warkentin, Lisette Kühlein, Thomas Steininger, Philipp Überla, Klaus Hueber, Susann Sebastião, Maria |
author_role | aut aut aut aut aut aut aut |
author_sort | Zeschick, Nikoletta |
author_variant | n z nz l w lw t k tk p s ps k ü kü s h sh m s ms |
building | Verbundindex |
bvnumber | BV049085276 |
callnumber-first | R - Medicine |
callnumber-label | R1 |
callnumber-raw | R1 |
callnumber-search | R1 |
callnumber-sort | R 11 |
callnumber-subject | R - General Medicine |
collection | ebook |
ctrlnum | (OCoLC)1392143850 (DE-599)DNB1266055452 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02245nmm a2200529zc 4500</leader><controlfield tag="001">BV049085276</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">230801s2022 gw |||| o||u| ||||||eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1266055452</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-215998</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1392143850</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1266055452</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">R1</subfield><subfield code="2">lcc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">615.3</subfield><subfield code="2">23ksdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">2\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zeschick, Nikoletta</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project</subfield><subfield code="c">Nikoletta Zeschick, Lisette Warkentin, Thomas Kühlein, Philipp Steininger, Klaus Überla, Susann Hueber, Maria Sebastião</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen ; Nürnberg</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicine.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Statistics.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medicine/Public Health, general.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Biomedicine, general.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Statistics for Life Sciences, Medicine, Health Sciences.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Warkentin, Lisette</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kühlein, Thomas</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Steininger, Philipp</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Überla, Klaus</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hueber, Susann</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sebastião, Maria</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">Pilot and Feasibility Studies</subfield><subfield code="g">Vol. 8 (2022)</subfield><subfield code="o">10.1186/s40814-022-01088-y</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://open.fau.de/handle/openfau/21599</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-215998</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034347135</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">emakn</subfield><subfield code="c">0,16263</subfield><subfield code="d">20220823</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emakn</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">emasg</subfield><subfield code="c">0,40103</subfield><subfield code="d">20220823</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emasg</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">npi</subfield><subfield code="d">20220822</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#npi</subfield></datafield></record></collection> |
id | DE-604.BV049085276 |
illustrated | Not Illustrated |
index_date | 2024-07-03T22:28:29Z |
indexdate | 2024-07-10T09:54:54Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034347135 |
oclc_num | 1392143850 |
open_access_boolean | 1 |
owner | DE-29 |
owner_facet | DE-29 |
physical | 1 Online-Ressource |
psigel | ebook |
publishDate | 2022 |
publishDateSearch | 2022 |
publishDateSort | 2022 |
publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg |
record_format | marc |
spelling | Zeschick, Nikoletta Verfasser aut Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project Nikoletta Zeschick, Lisette Warkentin, Thomas Kühlein, Philipp Steininger, Klaus Überla, Susann Hueber, Maria Sebastião Erlangen ; Nürnberg Friedrich-Alexander-Universität Erlangen-Nürnberg 2022 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Medicine. Statistics. Medicine/Public Health, general. Biomedicine, general. Statistics for Life Sciences, Medicine, Health Sciences. Warkentin, Lisette Verfasser aut Kühlein, Thomas Verfasser aut Steininger, Philipp Verfasser aut Überla, Klaus Verfasser aut Hueber, Susann Verfasser aut Sebastião, Maria Verfasser aut Sonderdruck aus Pilot and Feasibility Studies Vol. 8 (2022) 10.1186/s40814-022-01088-y https://open.fau.de/handle/openfau/21599 Verlag kostenfrei Volltext https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-215998 Resolving-System kostenfrei Volltext 1\p emakn 0,16263 20220823 DE-101 https://d-nb.info/provenance/plan#emakn 2\p emasg 0,40103 20220823 DE-101 https://d-nb.info/provenance/plan#emasg 3\p npi 20220822 DE-101 https://d-nb.info/provenance/plan#npi |
spellingShingle | Zeschick, Nikoletta Warkentin, Lisette Kühlein, Thomas Steininger, Philipp Überla, Klaus Hueber, Susann Sebastião, Maria Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project Medicine. Statistics. |
title | Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project |
title_auth | Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project |
title_exact_search | Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project |
title_exact_search_txtP | Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project |
title_full | Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project Nikoletta Zeschick, Lisette Warkentin, Thomas Kühlein, Philipp Steininger, Klaus Überla, Susann Hueber, Maria Sebastião |
title_fullStr | Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project Nikoletta Zeschick, Lisette Warkentin, Thomas Kühlein, Philipp Steininger, Klaus Überla, Susann Hueber, Maria Sebastião |
title_full_unstemmed | Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project Nikoletta Zeschick, Lisette Warkentin, Thomas Kühlein, Philipp Steininger, Klaus Überla, Susann Hueber, Maria Sebastião |
title_short | Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project |
title_sort | active monitoring of adverse reactions following covid 19 and other vaccinations a feasibility study as part of the covako project |
topic | Medicine. Statistics. |
topic_facet | Medicine. Statistics. |
url | https://open.fau.de/handle/openfau/21599 https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-215998 |
work_keys_str_mv | AT zeschicknikoletta activemonitoringofadversereactionsfollowingcovid19andothervaccinationsafeasibilitystudyaspartofthecovakoproject AT warkentinlisette activemonitoringofadversereactionsfollowingcovid19andothervaccinationsafeasibilitystudyaspartofthecovakoproject AT kuhleinthomas activemonitoringofadversereactionsfollowingcovid19andothervaccinationsafeasibilitystudyaspartofthecovakoproject AT steiningerphilipp activemonitoringofadversereactionsfollowingcovid19andothervaccinationsafeasibilitystudyaspartofthecovakoproject AT uberlaklaus activemonitoringofadversereactionsfollowingcovid19andothervaccinationsafeasibilitystudyaspartofthecovakoproject AT huebersusann activemonitoringofadversereactionsfollowingcovid19andothervaccinationsafeasibilitystudyaspartofthecovakoproject AT sebastiaomaria activemonitoringofadversereactionsfollowingcovid19andothervaccinationsafeasibilitystudyaspartofthecovakoproject |